SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 46.56 |
| Enterprise Value ($M) | 35.37 |
| Book Value ($M) | 4.38 |
| Book Value / Share | 0.22 |
| Price / Book | 10.63 |
| NCAV ($M) | 4.21 |
| NCAV / Share | 0.22 |
| Price / NCAV | 11.05 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -5.46 |
| Return on Assets (ROA) | -1.44 |
| Return on Equity (ROE) | -2.44 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.55 |
| Current Ratio | 1.55 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 11.96 |
| Assets | 12.13 |
| Liabilities | 7.75 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -28.81 |
| Net Income | -27.59 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -24.71 |
| Cash from Investing | -0.01 |
| Cash from Financing | 18.30 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
(click for more detail) |
||
| Similar Companies | |
|---|---|
| ABEO – Abeona Therapeutics Inc. | ABVC – ABVC BioPharma, Inc. |
| ACB – Aurora Cannabis Inc. | ACHV – Achieve Life Sciences, Inc. |
| ACXP – Acurx Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io